CANCER develops by accumulating stepwise genetic mutations in multiple genes that eventually lead to phenotypes such as uncontrolled proliferation and evasion of apoptosis ([@bib50]; [@bib15]). Genome instability is an enabling characteristic of cancer, by increasing the likelihood of accumulating mutations in multiple driver genes ([@bib15]). Genome destabilizing mutations are thought to occur early during tumor development, reducing the fidelity of DNA transmission and repair, and thereby increasing the likelihood of accumulating multiple gene mutations ([@bib34]; [@bib15]).

Genome instability can be classified under two distinct phenotypes: defects that increase mutation rate (mutator phenotype) and defects that increase the rate of aberrations to chromosome number or structure (chromosome instability or CIN). According to the mutator hypothesis, the high rate of genetic changes observed in cancer can be accounted for only by mutations that increase the mutation rate ([@bib27]). For example, some deficiencies in DNA damage repair components will increase the spontaneous mutation rate, allowing the cells to acquire mutations that may offer a selective advantage and aid in the evolution and progression of tumors ([@bib15]).

The budding yeast *Saccharomyces cerevisiae* has been a valuable model system for delineating pathways involved in genome instability, and screens in yeast have identified mutator alleles that increase genome instability ([@bib17]; [@bib52]; [@bib44]). A forward mutation screen with the nonessential yeast deletion collection identified 33 genes whose null mutations resulted in a mutator phenotype ([@bib17]), and 38 essential genes were identified in another screen ([@bib45]). Together, these screens and single gene studies generate a list of 127 yeast mutator alleles ([@bib45]). However, these studies were limited to studying loss-of-function (LOF, nonessential genes) or reduction-of-function (ROF, essential genes) alleles ([@bib17]; [@bib45]).

As more cancer genomes are sequenced, it is becoming apparent that somatic copy number amplifications (SCNAs) are one of the most frequent genetic perturbations in cancer ([@bib39]). High recurrence of SCNAs suggests that some may contain cancer drivers ([@bib39]); however, a majority of recurrently amplified regions in tumor genomes (\> 70%) do not contain known oncogenes or tumor suppressors ([@bib53]). Since amplified regions often encompass multiple genes, identifying drivers remains a challenge ([@bib53]), further emphasizing the need for methods to identify functionally relevant genes for tumor biology and progression within SCNAs.

To model potential effects on genome stability of gene amplification and/or overexpression, a genome-wide screen for an overexpression-induced mutator phenotype was conducted. For this purpose, we systematically overexpressed ∼85% of the yeast open reading frames using an inducible promoter and assessed increases in the forward mutation rate. We identified 37 genes that we will refer to as dosage mutator (dMutator) genes, the majority of which are involved in DNA replication and DNA damage repair. The top five genes with the highest mutation rate were analyzed further. Overexpressing the DNA helicase *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* (mutator phenotype 1), the yeast homolog of human FANCM, led to the strongest dMutator phenotype, increasing the mutation rate by over 200-fold. Using a series of genetic and functional assays, we show that this phenotype is helicase- and translesion synthesis (TLS)-independent, and DEAH-box function- and *[RAD27](http://www.yeastgenome.org/locus/S000001596/overview)*-dependent. Thus, the mutator phenotype of *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression is distinct from that published for *[mph1](http://www.yeastgenome.org/locus/S000001441/overview)*Δ cells, and suggests a novel gain-of-function mechanism leading to the mutator phenotype. Understanding how gene overexpression can lead to genome instability is a step toward interpreting the roles of amplified and/or overexpressed genome maintenance factors in cancer.

Materials and Methods {#s1}
=====================

Yeast strains and plasmids {#s2}
--------------------------

Strains and plasmids used are listed in Supplemental Material, [Table S2](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.192211/-/DC1/TableS2.xlsx). Strain construction by homologous recombination at chromosomal loci was done using standard methods and confirmed by PCR ([@bib28]). Unless otherwise indicated, standard synthetic media lacking appropriate amino acids for plasmid selection with 2% galactose were used for mutation rate, and other assays. Site-directed mutagenesis of *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* in pDONR221 was performed using a QuickChange kit (Stratagene, La Jolla, CA) following the manufacturer's protocols. All clones were confirmed by sequencing. Genes were shuttled between vectors using Gateway Cloning (Life Technologies). Expression clones were obtained from the Lindquist Gateway Vector collection ([@bib1]).

Dosage mutator screens and confirmations {#s3}
----------------------------------------

We used synthetic genetic array (SGA) technology to introduce a wild type *[CAN1](http://www.yeastgenome.org/locus/S000000789/overview)* gene into the overexpression array ([@bib48]). A query strain containing *[avt2](http://www.yeastgenome.org/locus/S000000790/overview)*∆::KANMX was crossed to the yeast full-length expression ready (FLEX) array, each containing a plasmid with a single gene under the control of the *[GAL1](http://www.yeastgenome.org/locus/S000000224/overview)* promoter ([@bib8]). The *[AVT2](http://www.yeastgenome.org/locus/S000000790/overview)* gene is immediately adjacent to the *[CAN1](http://www.yeastgenome.org/locus/S000000789/overview)* gene; thus, *[avt2](http://www.yeastgenome.org/locus/S000000790/overview)*∆::KANMX provides a linked marker for selection of spores carrying the wild-type *[CAN1](http://www.yeastgenome.org/locus/S000000789/overview)* locus. Following replica pinning steps, we generated an output array containing the *[avt2](http://www.yeastgenome.org/locus/S000000790/overview)*∆::KANMX and the individual overexpression plasmids.

Cells were taken from the haploid selection plates and streaked to single colonies on haploid selection medium (SD-U-L-K+G418+Thialysine) and grown for 2 days at 30°. Two induction steps were used to maximize the overexpression of genes from the plasmids. For the first induction, individual colonies were selected from the haploid selection plates and patched in duplicate onto medium containing galactose (SG-U-L-K+G418+Thialysine) and grown for 2 days at 30°. Subsequently, for the second induction, cells from these patches were patched again into 1 cm × 1 cm patches on galactose-containing medium (SG-URA+G418). Patches were grown for 2 days at 30° and cells were replica plated onto CAN^R^ selection plates (SD-R+ 50 μg/ml Canavanine). Plates were scored manually by counting colonies after incubating at 30° for 2--3 days.

Direct transformations were used to validate our hits from the genome-wide mutator screen. Plasmids from the FLEX array were verified by DNA sequencing, and then transformed directly into a wild-type BY4741 strain, and single colonies were patched twice, in quadruplicate, onto galactose containing media (SG-U) for induction. Patches were then replica plated onto canavanine plates (SD-R+CAN) and scored as above.

Fluctuation analyses {#s4}
--------------------

Mutation rates per cell division were adapted from a previously described assay ([@bib24]). Briefly, four independent transformants from each strain were grown to saturation in synthetic complete medium lacking uracil and supplemented with galactose (SG-URA). Each saturated culture was diluted 1:10,000 into 24 wells of SG-URA and grown for 2 days at 30°. Six random wells for each gene being tested were pooled and used to determine an average cell count using a TC20 cell counter (Bio-Rad, Hercules, CA). The remaining 18 wells were plated onto plates containing medium supplemented with glucose and 50 μg/ml canavanine but lacking arginine (SD-ARG+Canavanine). Plates were incubated at 30° for 2--3 days. Plates were scored for the frequency of Can^R^ colonies. Rates per generation were determined using the Ma-Sandri-Sarkar maximum-likelihood method calculated by the FALCOR program ([@bib13]).

Serial spot dilutions {#s5}
---------------------

Strains were grown to saturation at 30° in synthetic complete medium lacking uracil. Cultures were diluted to an OD~600~ of 1 and plated in 10-fold serial dilutions onto plates supplemented with galactose and containing the DNA-damaging agents (DDAs) methyl methanesulfonate (MMS), camptothecin (CPT), and hydroxyurea (HU) at concentrations of 0.01%, 25 µg/ml, and 50 mM, respectively.

Growth curve and analysis {#s6}
-------------------------

Strains were grown to saturation at 30° in synthetic complete medium lacking uracil. Two microliters of the saturated culture was diluted into 200 µl of the appropriate medium containing galactose and DDAs (at concentrations specified above). OD~600~ measurements were measured by a Tecan M200 plate reader at 30 min intervals for 72 hr at 30°. Area-under-the-curve analysis was performed as previously described ([@bib14]).

Chromosome region specific effects {#s7}
----------------------------------

Strains containing *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* located at different locations along chromosome VI ([@bib24]) were transformed with *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression plasmid marked with *[HIS3](http://www.yeastgenome.org/locus/S000005728/overview)*. Transformants were patched in quadruplicate onto SG-URA-HIS medium and incubated at 30° for 2 days to induce overexpression. Patches were replica-plated onto SD-URA+5-FOA and incubated for 2 days.

Dependence on TLS pathway {#s8}
-------------------------

TLS mutants, *[rev1](http://www.yeastgenome.org/locus/S000005873/overview)Δ*, *[rev3](http://www.yeastgenome.org/locus/S000006088/overview)Δ* and *[rad30](http://www.yeastgenome.org/locus/S000002827/overview)Δ*, from the yeast deletion collection ([@bib51]) were transformed with the *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression plasmid and were patched onto SG-URA plates in triplicate. After 2 days incubation at 30°, patches were replica plated onto SD-R+canavanine and incubated for 2--3 days at 30°.

Data availability {#s9}
-----------------

Strains are available upon request. [Table S2](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.192211/-/DC1/TableS2.xlsx) contains all strains and plasmids used in this study.

Results {#s10}
=======

Systematic identification of dmutator genes using overexpression {#s11}
----------------------------------------------------------------

To uncover genes whose overexpression results in an increased mutation rate, we performed a genome-wide screen in yeast. We screened an arrayed collection of yeast strains overexpressing ∼5100 genes under the control of a galactose-inducible promoter for increased forward mutagenesis of the *[CAN1](http://www.yeastgenome.org/locus/S000000789/overview)* marker ([@bib16]; [@bib8]). Using SGA technology ([@bib48]), we introduced a wild-type copy of the *[CAN1](http://www.yeastgenome.org/locus/S000000789/overview)* gene into each of the yeast strains in the overexpression array, and screened for canavanine resistant (CAN^R^) mutants in triplicate patches ([Figure 1A](#fig1){ref-type="fig"}). After screening ∼5100 genes and confirming the primary hits with direct tests using sequence verified plasmids (see *Materials and Methods*), we generated a list of 37 dMutator genes whose overexpression increased the frequency of CAN^R^ mutants as compared to a vector alone control ([Table 1](#t1){ref-type="table"}). Approximately half of the dmutator genes (18/37) function in biological pathways such as DNA damage repair, DNA replication, or transcription, processes well known to influence genome instability (Saccharomyces Genome Database). For 12 of the genes, overexpression also increases chromosome instability ([@bib9]), highlighting the established considerable overlap between the mutator and chromosome instability phenotypes ([@bib43]).

![Dosage mutator (dMutator) screen workflow. (A) The overexpression array was mated to a query strain with *avt2*Δ::KANMX, which is immediately adjacent to the wild-type *CAN1* gene using SGA. Following replica pinning steps, a haploid output array was generated where each strain contained both a unique gene overexpression plasmid and the wild type *CAN1* gene. Haploid cells were streaked onto selective medium to obtain single colonies, and overexpression was induced by plating on medium containing 2% galactose. Cells were replica plated onto medium containing canavanine 48 hr postinduction to assess the mutator phenotype. (B) Top dMutator genes from our screen overexpressing the indicated genes with the vector alone control for comparison. *MLH1* was tested as a positive control. Each gene was tested in triplicate and each patch represents an independent transformant. For a complete list see [Table 1](#t1){ref-type="table"}. (C) Overexpression of *MPH1*, *UBP12*, *PIF1*, *RRM3*, and *DNA2* resulted in an increased mutation rate \> 2-fold higher compared to a vector alone control. Mutation rates were quantified using fluctuation analysis. Error bars represent 95% confidence intervals with the average mutation rate shown above each bar.](975fig1){#fig1}

###### Validated dMutator genes identified on solid media

  ORF       Gene
  --------- ---------
  YBR234C   ARC40
  YER177W   BMH1
  YNL042W   BOP3
  YMR078C   CTF18
  YHR164C   DNA2
  YKL204W   EAP1
  YDR434W   GPI17
  YDR378C   LSM6
  YLR274W   MCM5
  YNL173C   MDG1
  YIR002C   MPH1
  YGR220C   MRPL9
  YKR087C   OMA1
  YPR162C   ORC4
  YML061C   PIF1
  YLR196W   PWP1
  YML032C   RAD52
  YGL163C   RAD54
  YDR004W   RAD57
  YBR087W   RFC5
  YGL044C   RNA15
  YBR181C   RPS6B
  YHR031C   RRM3
  YBR130C   SHE3
  YFL008W   SMC1
  YGL207W   SPT16
  YML010W   SPT5
  YHR041C   SRB2
  YGL097W   SRM1
  YLR005W   SSL1
  YCR042C   TAF2
  YOL006C   TOP1
  YJL197W   UBP12
  YIL017C   VID28
  YDR248C   YDR248C
  YGR126W   YGR126W
  YHR122W   YHR122W
  YMR167W   MLH1

Prior to this work, *[MLH1](http://www.yeastgenome.org/locus/S000004777/overview)* was the only previously known dmutator gene ([@bib42]). Since it was not in the overexpression array, we tested directly the overexpression of *[MLH1](http://www.yeastgenome.org/locus/S000004777/overview)* in our assay. Indeed, overexpression of *[MLH1](http://www.yeastgenome.org/locus/S000004777/overview)* induced a dMutator phenotype under a galactose-inducible promoter ([Figure 1B](#fig1){ref-type="fig"}).

Determining mutation rate by fluctuation analysis {#s12}
-------------------------------------------------

To determine the mutation rate of the dMutator genes, we used fluctuation analysis ([@bib30]; [@bib24]) and selected the top five dMutator genes, *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)*, *[UBP12](http://www.yeastgenome.org/locus/S000003733/overview)*, *[PIF1](http://www.yeastgenome.org/locus/S000004526/overview)*, *[RRM3](http://www.yeastgenome.org/locus/S000001073/overview)*, and *[DNA2](http://www.yeastgenome.org/locus/S000001207/overview)*, for further analysis. Overexpressing any one of these genes increased the mutation rate by at least 3-fold compared to a vector alone control ([Figure 1C](#fig1){ref-type="fig"}). Since four of these genes encode helicase activity, we reasoned that something common to ectopic helicase activity could be driving mutagenesis. To assess this possibility, we directly retested 48 DNA helicases using the *[CAN1](http://www.yeastgenome.org/locus/S000000789/overview)* mutator assay to determine whether they had been false negatives in the screen ([Table S1](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.192211/-/DC1/TableS1.xlsx)). However, none of the additional helicases tested conferred a mutator phenotype when overexpressed, suggesting both that helicase activity alone is not a predictor of the dMutator phenotype and that the false negative rate of our assay was probably very low. Of the five identified dMutator genes, *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)*, a 3′--5′ DNA helicase and a sequence homolog of the human FANCM, resulted in a \>200-fold increase in mutation rate ([Figure 1C](#fig1){ref-type="fig"}). While *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* deletion also results in a mutator phenotype ([@bib10]), the mutation rates are dramatically different ([Table 2](#t2){ref-type="table"}).

###### Mutation rates of *MPH1* overexpression and deletion

               Mutation Rate (10^−7^)   95% C.I. Upper Bound (10^−7^)   95% C.I. Lower Bound (10^−7^)
  ------------ ------------------------ ------------------------------- -------------------------------
  *GAL-MPH1*   224                      251                             199
  *mph1Δ*      11.1                     12.6                            9.83

Dosage mutator genes affect DNA metabolism {#s13}
------------------------------------------

It is clear how the LOF or the ROF of a cellular protein may lead to a phenotype such as an increased mutator rate; however, it is not as clear how overexpression may affect this phenotype. Therefore, we wanted to further explore the mechanism behind the mutator phenotype for our top five dMutator genes. LOF alleles of two of the top five dMutator genes, *[PIF1](http://www.yeastgenome.org/locus/S000004526/overview)* and *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)*, also increases the mutation rate ([@bib10]; [@bib17]), suggesting that, in these instances, overexpression may phenocopy LOF. To test this possibility, we chose to examine whether the phenotypic concurrence between overexpression and LOF will hold true for additional phenotypes.

Defective DNA repair is a well-established mechanism that leads to a mutator phenotype ([@bib18]), which often renders cells hypersensitive to DDAs. Thus, sensitivity to DDAs was an independent assay that could be utilized to compare directly the overexpression and LOF alleles of the dMutator genes. We tested the sensitivity of the top five dMutator genes to three DDAs---methyl methanesulfonate (MMS), hydroxyurea (HU) and camptothecin (CPT)---along with LOF alleles for *[mph1](http://www.yeastgenome.org/locus/S000001441/overview)Δ*, *[ubp12](http://www.yeastgenome.org/locus/S000003733/overview)Δ*, and *[rrm3](http://www.yeastgenome.org/locus/S000001073/overview)Δ* ([Figure 2, A and B](#fig2){ref-type="fig"}). Direct comparison data were not collected for *[DNA2](http://www.yeastgenome.org/locus/S000001207/overview)* as it is an essential gene and *[pif1](http://www.yeastgenome.org/locus/S000004526/overview)Δ* does not grow on galactose ([Figure 2A](#fig2){ref-type="fig"}). Strains were determined to be "sensitive" or "not-sensitive" to DDAs based on relative percent fitness as measured by area-under-the-curve in liquid growth assays (*P* \< 0.05) ([Figure 2C](#fig2){ref-type="fig"}). Overexpressing *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* sensitized cells to all three DDAs, whereas overexpressing *[UBP12](http://www.yeastgenome.org/locus/S000003733/overview)* and *[RRM3](http://www.yeastgenome.org/locus/S000001073/overview)* increased sensitivity only to MMS and HU, or MMS and CPT, respectively ([Figure 2C](#fig2){ref-type="fig"}). Thus, the sensitivity profiles for *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)*, *[RRM3](http://www.yeastgenome.org/locus/S000001073/overview)*, and *[UBP12](http://www.yeastgenome.org/locus/S000003733/overview)* overexpression were distinct from the sensitivity profile of the corresponding deletes, suggesting a different mode of action for overexpression-induced mutator phenotype.

![Overexpression of dMutator genes induces sensitivity to DDAs. (A) Serial spot dilutions of dMutator genes and respective deletion mutants on galactose, in the presence of the DDAs indicated. Deletion mutants were transformed with empty vector to enable tests on comparable growth medium. (B) Liquid growth curves of the dMutator genes and respective deletion mutants in galactose and in the presence of the indicated DDAs. (C) DDA sensitivities of dmutator genes and corresponding deletion mutants based on the liquid growth assays. Numbers represent relative percent fitness as measured by area-under-the-curve for each strain in triplicate. Red shading represents sensitive strains, and green shading represents strains that are not sensitive to drugs (*P* \< 0.05). (D) Sample images of a reporter strain with Rad52-GFP was transformed with a plasmid overexpressing *RRM3* or a vector alone control. (E) Quantified data for Rad52-foci in strains overexpressing dMutator genes and a *rrm3*Δ. Data summarizes three independent experiments where \> 100 cells were counted for each replicate.](975fig2){#fig2}

We further tested the dMutator genes for the presence of increased DNA damage using [Rad52](http://www.yeastgenome.org/locus/S000004494/overview) as a proxy. [Rad52](http://www.yeastgenome.org/locus/S000004494/overview) is essential for homologous recombination and forms foci in response to double strand breaks (DSBs) leading to recombination events ([@bib26]; [@bib46]). The overexpression of one dMutator gene, *[RRM3](http://www.yeastgenome.org/locus/S000001073/overview)*, increased Rad52-foci ([Figure 2, D and E](#fig2){ref-type="fig"}). *[RRM3](http://www.yeastgenome.org/locus/S000001073/overview)* deletion also increases [Rad52](http://www.yeastgenome.org/locus/S000004494/overview) foci ([@bib2]); therefore, these data suggest that cells that either lack or overexpress *[RRM3](http://www.yeastgenome.org/locus/S000001073/overview)* may induce dependence on DNA repair through homologous recombination. However, this is the only phenotype for which we see concurrence between *[RRM3](http://www.yeastgenome.org/locus/S000001073/overview)* overexpression and deletion, as the DDA sensitivity profile for *[RRM3](http://www.yeastgenome.org/locus/S000001073/overview)* overexpression is distinct from the deletion mutant, and *[rrm3](http://www.yeastgenome.org/locus/S000001073/overview)Δ* does not induce a mutator phenotype. Together our analysis implies that the dMutator phenotype is not generally due to a LOF upon overexpression and must relate to an inappropriate gain-of-function.

The dMutator phenotype of MPH1 is partially dependent on the TLS pathway {#s14}
------------------------------------------------------------------------

We wanted to further understand the mechanisms behind the mutator phenotype of *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)*, as it was the strongest dMutator gene identified in our screen. The *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* deletion also results in a mutator phenotype ([@bib10]); however, the mechanism behind the mutator phenotype may be different since the mutation rates are dramatically different between *[mph1](http://www.yeastgenome.org/locus/S000001441/overview)*Δ and *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression ([Table 2](#t2){ref-type="table"}), and because the DDA sensitivity profiles for *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* deletion and the overexpressor are distinct ([Figure 2C](#fig2){ref-type="fig"}).

The mutator phenotype of the *[mph1](http://www.yeastgenome.org/locus/S000001441/overview)*Δ mutant is dependent on TLS ([@bib40]; [@bib41]). TLS allows bypassing of DNA lesions so replication can resume, and involves several DNA polymerases that include [Rev3](http://www.yeastgenome.org/locus/S000006088/overview) (DNA polymerase zeta), [Rad30](http://www.yeastgenome.org/locus/S000002827/overview) (DNA polymerase eta), and [Rev1](http://www.yeastgenome.org/locus/S000005873/overview) (deoxycytidyl transferase) ([@bib20]; [@bib11]). A large portion of spontaneous mutations in the *[mph1](http://www.yeastgenome.org/locus/S000001441/overview)*Δ mutants arises by Rev3-mediated mutagenic bypass of DNA lesions using the error-prone TLS pathway ([@bib40]). Therefore, we tested if the mutator phenotype of *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression also relied on the TLS pathway. We transformed deletion mutants of the TLS polymerases *[REV1](http://www.yeastgenome.org/locus/S000005873/overview)*, *[REV3](http://www.yeastgenome.org/locus/S000006088/overview)*, and *[RAD30](http://www.yeastgenome.org/locus/S000002827/overview)* with a plasmid overexpressing *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* and assayed for a mutator phenotype at *[CAN1](http://www.yeastgenome.org/locus/S000000789/overview)*. We did not observe a reduction in the frequency of CAN^R^ mutants in the individual TLS mutants ([Figure 3A](#fig3){ref-type="fig"}). We next generated double and triple mutants of TLS polymerases and quantified the mutation rate of *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression in these mutants. Removal of *[REV3](http://www.yeastgenome.org/locus/S000006088/overview)* together with *[REV1](http://www.yeastgenome.org/locus/S000005873/overview)* or *[RAD30](http://www.yeastgenome.org/locus/S000002827/overview)* partially reduced the frequency of CAN^R^ mutants, and the simultaneous removal of all three TLS polymerases also reduced this frequency, although not more than the double mutants ([Figure 3A](#fig3){ref-type="fig"}). Thus, similar to the *[mph1](http://www.yeastgenome.org/locus/S000001441/overview)*Δ mutants, the mutagenesis induced by overexpression of *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* relies on Rev3-mediation mutagenic bypass; however, unlike the mutator phenotype of *[mph1](http://www.yeastgenome.org/locus/S000001441/overview)*Δ, mutations caused by *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression are only partially dependent on the TLS pathway.

![dMutator phenotypes of *MPH1*. (A) Mutation rates for overexpression of *MPH1* in *rev1*Δ, *rev3*Δ, or *rad30*Δ mutants, along with the vector alone control, as determined by fluctuation analysis. Error bars represent 95% confidence intervals with the average mutation rate shown above each bar. Empty vector (white bars), MPH1 expressing (gray bars). (B) Mutation rates when *MPH1* catalytic mutants, ATPase mutant (K113Q), a helicase mutant (Q603D), individual DEAH-box mutants (D209N, E210Q, and H212D), combined double DEAH-box mutants, and the triple DEAH-box mutants, were overexpressed and assessed using fluctuation analysis. Error bars represent 95% confidence intervals with the average mutation rate shown above each bar.](975fig3){#fig3}

The dMutator phenotype of Mph1 depends on the DEAH-box but not on catalytic activity {#s15}
------------------------------------------------------------------------------------

To further examine the dMutator phenotype, we next turned to the catalytic activities of *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)*. [Mph1](http://www.yeastgenome.org/locus/S000001441/overview) possesses three conserved motifs: a DEAH-box ([@bib40]), an ATPase domain ([@bib37]), and a helicase domain ([@bib22]). To determine whether catalytic activity (helicase and ATPase) and DEAH-box functions were necessary for the dMutator phenotype, we generated five point mutations that have been described previously. It has been shown that all these mutant proteins are expressed at similar levels and localize to the nucleus ([@bib40]). These include an ATPase mutant (K113Q), a helicase mutant (Q603D), and three DEAH-box mutants (D209N, E210Q, and H212D) ([@bib4]). All of these mutations are predicted to impair the helicase activity, and one, D209N, to lack both ATPase and helicase activity but was proficient in DNA binding *in vitro* ([@bib38]).

The overexpression of all five single point mutants resulted in an overexpression mutator phenotype that was similar to that seen when wild-type *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* was overexpressed ([Figure 3B](#fig3){ref-type="fig"}). Therefore, similar to observations made with *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression-induced gross chromosomal rearrangement ([@bib4]), the mutator phenotype of *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression does not appear to be due to the hyperactivation of the helicase or ATPase activities. However, while single DEAH point mutations had no effect, overexpressing double DEAH-box mutants (D209N, E210Q), (D209N, H212D), and (E210Q, H212D), or the triple DEAH-box mutant (D209N, E210Q, and H212D) with impaired Mg^+2^ binding, ATP hydrolysis and/or NTP-dependent conformational change, and possibly protein stability or interaction defects ([@bib40]), lowered the mutation rate tremendously to near normal levels as compared to *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* ([Figure 3B](#fig3){ref-type="fig"}).

Mutations caused by MPH1 overexpression are localized to the telomeres {#s16}
----------------------------------------------------------------------

Overexpression of *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* also leads to the accumulation of single-stranded DNA (ssDNA) at telomeres ([@bib29]). ssDNA can be more prone to damage since the nucleotides are more exposed to reactive species. Given that *[CAN1](http://www.yeastgenome.org/locus/S000000789/overview)* was at the distal region of chromosome V, it seemed possible that the increased mutation rate at *[CAN1](http://www.yeastgenome.org/locus/S000000789/overview)* is due to the presence of ssDNA. To determine whether gene position on the chromosome affected the mutation rate, we used strains in which *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* was integrated at different locations on chromosome III ([Figure 4A](#fig4){ref-type="fig"}) ([@bib24]). Overexpressing *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* exhibited a mutator phenotype only when *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* was located in the most telomeric regions ([Figure 4B](#fig4){ref-type="fig"}), while this phenotype is more generalized for other dMutator genes such as *[UBP12](http://www.yeastgenome.org/locus/S000003733/overview)* and *[DNA2](http://www.yeastgenome.org/locus/S000001207/overview)* ([Figure S1, A and B](http://www.genetics.org/lookup/suppl/doi:10.1534/genetics.116.192211/-/DC1/FigureS1.pdf)).

![*MPH1* dMutator phenotype is position-dependent and is epistatic to Rad27. (A) Schematic of absolute and relative positions of *URA3* position along chromosome III. The black circle represents the centromere, and the black boxes represent the location of the *URA3* gene relative to the centromere and the telomere. Numbers beside each schematic denotes the absolute position of *URA3* on the chromosome. (B) Strains containing *URA3* at positions indicated in (A) with a vector alone control or with the overexpression of *MPH1*. Each strain was assayed with four independent transformants. (C) The mutator phenotype of strains overexpressing *RAD27* (URA marked), *MPH1* (HIS marked), or both plasmids together along with the vector alone controls. (D) Mutation rates of strains overexpressing *RAD27*, *MPH1*, *RAD27*, and *MPH1*, as well as a *rad27Δ* strain overexpressing *MPH1* or a vector alone control assayed using fluctuation analysis. Error bars represent 95% confidence intervals, with the average mutation rate shown above each bar. (E) Synthetic dosage lethal interactions with *MPH1* for mutations that are synthetic lethal with a *RAD27*-null mutant. (F) Mutation rates for strains lacking *SGS1*, *MUS81*, and *SRS2* overexpressing *MPH1* or a vector alone control assayed using fluctuation analysis. Error bars represent 95% confidence intervals with the average mutation rate shown above each bar.](975fig4){#fig4}

The mutator phenotype of Mph1 is dependent on levels of Rad27 and Dna2 {#s17}
----------------------------------------------------------------------

Since the dMutator activity of [Mph1](http://www.yeastgenome.org/locus/S000001441/overview) depends on its DEAH box but not its specific catalytic activities, we reasoned that the mechanism may rely on competition for DNA binding with another DNA-binding protein. One ideal candidate is the flap endonuclease, [Rad27](http://www.yeastgenome.org/locus/S000001596/overview). Both [Mph1](http://www.yeastgenome.org/locus/S000001441/overview) and [Rad27](http://www.yeastgenome.org/locus/S000001596/overview) are known to bind DNA flap structures and work in Okazaki fragment processing ([@bib21], [@bib22]). One possibility is that when [Mph1](http://www.yeastgenome.org/locus/S000001441/overview) is overexpressed it outcompetes the action of [Rad27](http://www.yeastgenome.org/locus/S000001596/overview) from these structures, mimicking a *[RAD27](http://www.yeastgenome.org/locus/S000001596/overview)* deletion. Alternatively, [Mph1](http://www.yeastgenome.org/locus/S000001441/overview) has been shown to stimulate [Rad27](http://www.yeastgenome.org/locus/S000001596/overview) *in vitro*, and this hyperactivity could be mutagenic. Also, consistent with coordinated action of [Mph1](http://www.yeastgenome.org/locus/S000001441/overview) and [Rad27](http://www.yeastgenome.org/locus/S000001596/overview) is that deletion of *[RAD27](http://www.yeastgenome.org/locus/S000001596/overview)* has been reported to increase instability and ssDNA at telomeres ([@bib35]), and to cause a strong mutator phenotype ([@bib47]). Accordingly, while overexpressing *[RAD27](http://www.yeastgenome.org/locus/S000001596/overview)* alone had no effect on the mutator phenotype, overexpressing *[RAD27](http://www.yeastgenome.org/locus/S000001596/overview)* lowered the mutator phenotype caused by *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression (both qualitatively and quantitatively by fluctuation analysis) as compared to overexpressing *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* alone ([Figure 4, C and D](#fig4){ref-type="fig"}). Additionally, *[rad27](http://www.yeastgenome.org/locus/S000001596/overview)*Δ had a strong mutator phenotype that was not further enhanced by overexpression of *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* ([Figure 4D](#fig4){ref-type="fig"}). This epistatic relationship shows that *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression and *[RAD27](http://www.yeastgenome.org/locus/S000001596/overview)* deletion work in the same mutagenesis pathway. [Rad27](http://www.yeastgenome.org/locus/S000001596/overview) and [Dna2](http://www.yeastgenome.org/locus/S000001207/overview) work coordinately in Okazaki fragment processing ([@bib3]), and we also observed that overexpression of *[DNA2](http://www.yeastgenome.org/locus/S000001207/overview)* reduced significantly the dMutator effect of *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)*, suggesting that lagging strand replication may be a target for mutagenesis by the *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* dMutator activity ([Figure 4D](#fig4){ref-type="fig"}).

Given that the mutator phenotype of *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression phenocopies the LOF mutation of *[RAD27](http://www.yeastgenome.org/locus/S000001596/overview)*, we tested whether this concordance was limited to the mutator phenotype or holds true for other phenotypes such as negative genetic interactions. Negative genetic interactions such as synthetic lethality takes place when the observed fitness defect of a double mutant is significantly less than that of the expected fitness based on the fitness of the two single mutants ([@bib31]). Overexpression of *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* caused synthetic dosage lethality in strains lacking *[MUS81](http://www.yeastgenome.org/locus/S000002794/overview)*, *[ELG1](http://www.yeastgenome.org/locus/S000005670/overview)*, and *[MMS1](http://www.yeastgenome.org/locus/S000006368/overview)*, but had no phenotype in *[RAD1](http://www.yeastgenome.org/locus/S000005943/overview)*, *[CHL1](http://www.yeastgenome.org/locus/S000005929/overview)*, and *[EXO1](http://www.yeastgenome.org/locus/S000005559/overview)* deletions ([Figure 4E](#fig4){ref-type="fig"}). This suggests that the mutator phenotype of *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression is only partially redundant with loss of *[rad27](http://www.yeastgenome.org/locus/S000001596/overview)*Δ. Interestingly, among those tested, mutations with specific functions in handling DNA replication stress (*i.e.*, *[mus81](http://www.yeastgenome.org/locus/S000002794/overview)*Δ, *[elg1](http://www.yeastgenome.org/locus/S000005670/overview)*Δ, and *[mms1](http://www.yeastgenome.org/locus/S000006368/overview)*Δ) appear to be most negatively affected by *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression, possibly suggesting that the replication role of [Rad27](http://www.yeastgenome.org/locus/S000001596/overview) is the relevant activity.

To further establish that *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression increases mutation rate by either outcompeting or squelching its functional partners or those of [Rad27](http://www.yeastgenome.org/locus/S000001596/overview), we chose to examine the effect of removing, *[SGS1](http://www.yeastgenome.org/locus/S000004802/overview)*, *[MUS81](http://www.yeastgenome.org/locus/S000002794/overview)*, and *[SRS2](http://www.yeastgenome.org/locus/S000003628/overview)* on the dMutator phenotype. *[SGS1](http://www.yeastgenome.org/locus/S000004802/overview)* encodes another DNA helicase, which functions in parallel with [Mph1](http://www.yeastgenome.org/locus/S000001441/overview) to regulate the choice of homologous recombination pathway to be used ([@bib19]), the endonuclease [Mus81](http://www.yeastgenome.org/locus/S000002794/overview) and the [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) helicase also influence repair pathway choice and recombination intermediate processing ([@bib32]; [@bib33]). Deletion of *[SGS1](http://www.yeastgenome.org/locus/S000004802/overview)* or *[MUS81](http://www.yeastgenome.org/locus/S000002794/overview)* led to small but significant decreases in the dMutator phenotype of *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression ([Figure 4F](#fig4){ref-type="fig"}), while deletion of *[SRS2](http://www.yeastgenome.org/locus/S000003628/overview)* led to a \> 5-fold decrease in mutation rate ([Figure 4F](#fig4){ref-type="fig"}).

Discussion {#s18}
==========

A genome-wide screen for genes that, when overexpressed, increased the mutation rate, identified 37 dMutator genes in yeast. The majority of these genes belong to biological processes, such as DNA repair, previously known to impact mutation rate, and ∼30% of the dMutator genes also cause chromosome instability as seen previously for LOF and ROF mutations ([@bib44]). Incorporating the data from our screen with published data, a total of 210 genes are implicated in increasing the mutator phenotype in yeast ([@bib17]; [@bib44]).

The five strongest dMutator genes, *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)*, *[UBP12](http://www.yeastgenome.org/locus/S000003733/overview)*, *[PIF1](http://www.yeastgenome.org/locus/S000004526/overview)*, *[RRM3](http://www.yeastgenome.org/locus/S000001073/overview)*, and *[DNA2](http://www.yeastgenome.org/locus/S000001207/overview)*, had mutation rates at least two times greater than wild type ([Figure 1C](#fig1){ref-type="fig"}). Since four of these genes possess helicase activity, we tested directly whether ectopic helicase activity is responsible for the dMutator phenotype by overexpressing a panel of other DNA helicases, and found that helicase activity itself did not predict the dMutator phenotype. We further characterized the top five dMutator genes by examining their sensitivities to DDAs, and their effects on DNA integrity. Cells overexpressing any one of the five dMutator genes were sensitive to DDAs, implicating defective DNA repair as one possible mechanism for the dMutator phenotype ([Figure 2, A and B](#fig2){ref-type="fig"}). However, overexpression of only one gene, [Rrm3](http://www.yeastgenome.org/locus/S000001073/overview), induced higher than wild type levels of [Rad52](http://www.yeastgenome.org/locus/S000004494/overview) foci ([Figure 2E](#fig2){ref-type="fig"}). Consequently, the dMutator phenotype of [Rrm3](http://www.yeastgenome.org/locus/S000001073/overview) may be due to both increased DNA damage and defective DNA repair. When the DDA sensitivity profiles of *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)*, *[RRM3](http://www.yeastgenome.org/locus/S000001073/overview)*, and *[UBP12](http://www.yeastgenome.org/locus/S000003733/overview)* were compared directly to the corresponding LOF alleles there was no concurrence between the profiles, implying different mechanisms of action ([Figure 2C](#fig2){ref-type="fig"}). In the case of *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)*, whose LOF allele also induces a mutator phenotype, the unique sensitivity profile to DDAs suggests that overexpression does not mimic deletion in this case ([@bib49]). Taken together, these data suggest that dMutators are relatively rare, and, while they function in the same pathways as canonical mutators (such as DNA repair), overexpression causes mutations by different mechanisms as compared to LOF or ROF.

The differences in mechanism of action between overexpression and deletion were particularly pronounced for *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)*. *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression caused sensitivity to MMS, CPT, and HU, whereas *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* deletion caused sensitivity only to MMS ([Figure 2, A and B](#fig2){ref-type="fig"}). *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression also caused a higher mutation rate than the *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* deletion and, furthermore, the mutator phenotype caused by *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression was at least partially independent of TLS polymerases ([Figure 3A](#fig3){ref-type="fig"} and [Table 2](#t2){ref-type="table"}). We also showed that the *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* dMutator phenotype was independent of the helicase and ATPase activities of [Mph1](http://www.yeastgenome.org/locus/S000001441/overview), but was abrogated by simultaneously mutating either two or three residues in the DEAH domain ([Figure 3B](#fig3){ref-type="fig"}). These DEAH mutations may also abolish binding to Mg^+2^, ATP hydrolysis, and/or the NTP-dependent conformational change, suggesting to us that proper DEAH-box function is the essential feature of its dMutator mechanism. Alternatively, the result of the multiple DEAH mutants may be impaired protein- or DNA-binding interfaces, which could arise due to conformational changes in the protein or because the protein has become unstable. Either way our analysis implicates noncatalytic functions of [Mph1](http://www.yeastgenome.org/locus/S000001441/overview) in inducing *[CAN1](http://www.yeastgenome.org/locus/S000000789/overview)* hypermutation.

*[RAD27](http://www.yeastgenome.org/locus/S000001596/overview)* deletion causes a mutation rate comparable to *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression ([@bib17]), and an increase in telomeric ssDNA ([@bib35]), as has been seen previously with *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression ([@bib29]) ([Figure 4B](#fig4){ref-type="fig"}). Prompted by these similarities, we tested for genetic interactions between *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* and *[RAD27](http://www.yeastgenome.org/locus/S000001596/overview)*. Deletion of *[RAD27](http://www.yeastgenome.org/locus/S000001596/overview)* was epistatic to *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression with respect to mutation rate ([Figure 4D](#fig4){ref-type="fig"}). This suggested that hypermutation in [Mph1](http://www.yeastgenome.org/locus/S000001441/overview) overexpressing cells is mediated by impairing the [Rad27](http://www.yeastgenome.org/locus/S000001596/overview) pathway. Consistent with this interpretation, overexpressing *[RAD27](http://www.yeastgenome.org/locus/S000001596/overview)* or *[DNA2](http://www.yeastgenome.org/locus/S000001207/overview)* \[which works in parallel with [Rad27](http://www.yeastgenome.org/locus/S000001596/overview) in Okazaki fragment processing ([@bib3])\], together with *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* strongly reduced the mutation rate compared to *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* alone ([Figure 4C](#fig4){ref-type="fig"}). These data suggest that the relative stoichiometry of [Mph1](http://www.yeastgenome.org/locus/S000001441/overview), [Rad27](http://www.yeastgenome.org/locus/S000001596/overview), and [Dna2](http://www.yeastgenome.org/locus/S000001207/overview) is critical to prevent mutations.

Several lines of evidence support defective replication as a mechanism for the dMutator phenotype of *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)*: (1) *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression recapitulated the genetic interactions between *[rad27](http://www.yeastgenome.org/locus/S000001596/overview)*Δ and DNA replication fork protection factors such as *[mms1](http://www.yeastgenome.org/locus/S000006368/overview)*Δ, *[mus81](http://www.yeastgenome.org/locus/S000002794/overview)*Δ, and *[elg1](http://www.yeastgenome.org/locus/S000005670/overview)*Δ ([Figure 4E](#fig4){ref-type="fig"}); (2) the position specific mutation rate increases we saw for *[URA3](http://www.yeastgenome.org/locus/S000000747/overview)* at subtelomeric loci in Chr VI ([Figure 4B](#fig4){ref-type="fig"}) occur in late replicating regions of the chromosome ([@bib25]); and (3) removal of *[SRS2](http://www.yeastgenome.org/locus/S000003628/overview)* strongly suppressed the dMutator phenotype of *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression ([Figure 4F](#fig4){ref-type="fig"}). [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) has a previously identified antimutator activity in deletions of *[MMS2](http://www.yeastgenome.org/locus/S000003055/overview)*, a ubiquitin-conjugating enzyme required for postreplicative repair ([@bib6]). In addition, defects in Okazaki fragment processing caused by loss of *[RAD27](http://www.yeastgenome.org/locus/S000001596/overview)* have been shown to activate postreplicative repair via the exposure of ssDNA ([@bib35]). Indeed, as with our data on *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression, these authors showed that mutation rates in *[rad27](http://www.yeastgenome.org/locus/S000001596/overview)*Δ cells were suppressed only partially by deletion of *[REV3](http://www.yeastgenome.org/locus/S000006088/overview)* ([@bib5]).

Together, these data lead us to propose a model where high levels of [Mph1](http://www.yeastgenome.org/locus/S000001441/overview) lead to dysregulation of Okazaki fragment processing ([@bib21], [@bib22]), signaling via [Srs2](http://www.yeastgenome.org/locus/S000003628/overview) to the postreplicative repair and to damage-tolerance/TLS pathways, which together increase the frequency of mutations. This is particularly pronounced in late-replicating and/or subtelomeric regions, where both *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* overexpression or *[rad27](http://www.yeastgenome.org/locus/S000001596/overview)*Δ are known to enhance the exposure of ssDNA. While the enzymatic activity of [Mph1](http://www.yeastgenome.org/locus/S000001441/overview) is not required for the dMutator effect, increasing the concentration of [Rad27](http://www.yeastgenome.org/locus/S000001596/overview) or [Dna2](http://www.yeastgenome.org/locus/S000001207/overview) in the cell can revert the dMutator phenotype. Therefore, we favor the view that competition for DNA flap binding by excess [Mph1](http://www.yeastgenome.org/locus/S000001441/overview) may impair normal flap processing sufficiently to trigger mutations.

The human *[MPH1](http://www.yeastgenome.org/locus/S000001441/overview)* homolog *FANCM* is a breast cancer susceptibility gene that is characterized by missense or nonsense somatic mutations in cancer cells ([@bib23]; [@bib36]). There are also examples of *FANCM* overexpression in cancer that are of unknown significance ([@bib7]; [@bib12]). Our study shows that the overexpression of DNA repair proteins, specifically [Mph1](http://www.yeastgenome.org/locus/S000001441/overview), can cause imbalances in DNA transactions through competition to drive mutagenesis. Further analysis of the effects of gene overexpression on genome instability should reveal new mechanisms by which protein imbalances affect genome maintenance.
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